Organization Profile

You just read:

Resverlogix and China-based Shenzhen Hepalink Pharmaceutical Co., Ltd. Announce a Combination Licensing and Equity Arrangement

News provided by

Resverlogix Corp.

Apr 27, 2015, 07:00 ET